KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Exchange Rate Effect: 2021-2025

Historic Exchange Rate Effect for AbCellera Biologics (ABCL) over the last 5 years, with Sep 2025 value amounting to -$544,000.

  • AbCellera Biologics' Exchange Rate Effect fell 248.23% to -$544,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.4 million, marking a year-over-year decrease of 321.44%. This contributed to the annual value of -$2.6 million for FY2024, which is 544.31% down from last year.
  • Per AbCellera Biologics' latest filing, its Exchange Rate Effect stood at -$544,000 for Q3 2025, which was down 171.48% from $761,000 recorded in Q2 2025.
  • AbCellera Biologics' Exchange Rate Effect's 5-year high stood at $1.1 million during Q4 2023, with a 5-year trough of -$8.6 million in Q3 2022.
  • Moreover, its 3-year median value for Exchange Rate Effect was -$43,000 (2024), whereas its average is -$111,000.
  • Its Exchange Rate Effect has fluctuated over the past 5 years, first crashed by 3,841.01% in 2022, then surged by 1,869.77% in 2025.
  • Over the past 5 years, AbCellera Biologics' Exchange Rate Effect (Quarterly) stood at -$525,000 in 2021, then spiked by 169.33% to $364,000 in 2022, then spiked by 193.41% to $1.1 million in 2023, then tumbled by 302.25% to -$2.2 million in 2024, then slumped by 248.23% to -$544,000 in 2025.
  • Its last three reported values are -$544,000 in Q3 2025, $761,000 for Q2 2025, and $590,000 during Q1 2025.